Propafenone Hydrochloride Capsule, Extended Release
Product Images NDC 69680-132
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Propafenone Hydrochloride (NDC 69680-132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vitruvias Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Raft Kaplan-meier Analysis For The Tachycardia-free Period From Day 1 Of Randomization (Figure 01)
Propafenone Hydrochloride Extended-release Capsules, Usp 225 mg Bottle Label (225 60)
Propafenone Hydrochloride Extended-release Capsules, Usp 225 mg Bottle Label (225 500)
Propafenone Hydrochloride Extended-release Capsules, Usp 325 mg Bottle Label (325 60)
Propafenone Hydrochloride Extended-release Capsules, Usp 325 mg Bottle Label (325 500)
Propafenone Hydrochloride Extended-release Capsules, Usp 425 mg Bottle Label (425 60)
Propafenone Hydrochloride Extended-release Capsules, Usp 425 mg Bottle Label (425 500)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.